Phase 0/I/II Cancer Prevention Clinical Trials Program Clinical Trials
Title |
Intervention | NCT ID | Sponsor | Status |
|---|---|---|---|---|
| Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer | Retinoid 9cUAB30, Therapeutic Conventional Surgery | NCT02876640 | National Cancer Institute (NCI) | Recruiting |
| Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01 | Electronic Health Record Review | NCT04674228 | National Cancer Institute (NCI) | Active, not recruiting |
| Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis | Placebo Administration, Questionnaire Administration, Simvastatin | NCT02968810 | National Cancer Institute (NCI) | Active, not recruiting |
| Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis | Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration, Simvastatin, Placebo Administration | NCT02743364 | National Cancer Institute (NCI) | Active, not recruiting |
| Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to... | Afimoxifene, Laboratory Biomarker Analysis, Placebo, Tamoxifen Citrate | NCT02993159 | Northwestern University | Recruiting |
| Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial... | Imiquimod, Topical Fluorouracil | NCT03196180 | National Cancer Institute (NCI) | Active, not recruiting |
| Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy | Telapristone Acetate, Placebo, Laboratory Biomarker Analysis, Questionnaire Administration | NCT02314156 | Northwestern University | Active, not recruiting |
| Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive,... | Laboratory Biomarker Analysis, Sargramostim, pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine | NCT02780401 | University of Washington | Active, not recruiting |
| Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps | Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine, Quality-of-Life Assessment, Saline | NCT02134925 | National Cancer Institute (NCI) | Active, not recruiting |